Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius Medical Care AG & Co. KGaA    FME   DE0005785802

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Fresenius Medical Care : third-quarter net income beats on strong operations

10/29/2020 | 03:32am EST

(Reuters) - German dialysis specialist Fresenius Medical Care beat third-quarter net income expectations on Thursday, as it was able to maintain operations and minimize risk for its patients during the COVID-19 pandemic.

Net income of the world's largest provider of dialysis treatments came in at 354 million euros ($418.39 million) for the quarter ended Sept. 30, above analysts' average forecast of 332 million euros in a company-provided poll.

The company confirmed its 2020 targets for net income and revenue growth in the mid to high single digits.

($1 = 0.8461 euros)

(Reporting by Anna Rzhevkina in Gdansk; Editing by Rashmi Aich)


© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
FRESENIUS MEDICAL CARE AG & CO. KGAA 0.43% 70.24 Delayed Quote.6.03%
FRESENIUS SE & CO. KGAA 0.03% 37.67 Delayed Quote.-24.95%
All news about FRESENIUS MEDICAL CARE AG & CO. KGAA
11/24FRESENIUS SE : UBS remains Neutral
MD
11/19FMC FRESENIUS MEDICAL CARE AG & CO K : RBC reiterates its Neutral rating
MD
11/19FMC FRESENIUS MEDICAL CARE AG & CO K : Bernstein reiterates its Neutral rating
MD
11/19FRESENIUS SE : Bernstein reiterates its Buy rating
MD
11/17FMC FRESENIUS MEDICAL CARE AG & CO K : Jefferies reiterates its Neutral rating
MD
11/16FRESENIUS MEDICAL CARE : included for 11th time in Dow Jones Sustainability Inde..
PU
11/13FRESENIUS SE : Receives a Buy rating from Bernstein
MD
11/12FMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Neutral rating from Bernstein
MD
11/11FRESENIUS MEDICAL CARE AG & CO. KGAA : Notification and public disclosure of tra..
EQ
11/09Switzerland's Vifor strikes kidney drug deal with Angion
RE
More news
Financials (USD)
Sales 2020 21 231 M - -
Net income 2020 1 532 M - -
Net Debt 2020 15 175 M - -
P/E ratio 2020 16,1x
Yield 2020 1,67%
Capitalization 24 405 M 24 391 M -
EV / Sales 2020 1,86x
EV / Sales 2021 1,72x
Nbr of Employees 126 463
Free-Float 65,1%
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA
Duration : Period :
Fresenius Medical Care AG & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS MEDICAL CARE AG & CO. KGAA
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 95,34 $
Last Close Price 83,34 $
Spread / Highest target 34,4%
Spread / Average Target 14,4%
Spread / Lowest Target -23,7%
EPS Revisions
Managers
NameTitle
Rice Powell Chairman-Management Board
Dieter Schenk Chairman-Supervisory Board
Helen Giza Chief Financial Officer
Olaf Schermeier CEO-Global Research & Development
Franklin W. Maddux Global Chief Medical Officer